Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine Induced Wheal

ABSTRACT: Background: Antihistamines are the first line of treatment for chronic spontaneous urticaria. However, there is no effective method to predict whether an antihistamine will have a beneficial clinical effect or not. Objective: To assess whether the change in histamine-induced wheal and flar...

Full description

Autores:
Sánchez Caraballo, Jorge Mario
Zakzuk Sierra, Josefina
Cardona Villa, Ricardo
Tipo de recurso:
Article of investigation
Fecha de publicación:
2016
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/43153
Acceso en línea:
https://hdl.handle.net/10495/43153
Palabra clave:
Enfermedad Crónica
Chronic Disease
Antagonistas de los Receptores Histamínicos
Histamine Antagonists
Urticaria
Estudios Prospectivos
Prospective Studies
https://id.nlm.nih.gov/mesh/D002908
https://id.nlm.nih.gov/mesh/D006633
https://id.nlm.nih.gov/mesh/D014581
https://id.nlm.nih.gov/mesh/D011446
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id UDEA2_913ec6885e5051ab1e6ce3fb3532e263
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/43153
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine Induced Wheal
title Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine Induced Wheal
spellingShingle Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine Induced Wheal
Enfermedad Crónica
Chronic Disease
Antagonistas de los Receptores Histamínicos
Histamine Antagonists
Urticaria
Estudios Prospectivos
Prospective Studies
https://id.nlm.nih.gov/mesh/D002908
https://id.nlm.nih.gov/mesh/D006633
https://id.nlm.nih.gov/mesh/D014581
https://id.nlm.nih.gov/mesh/D011446
title_short Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine Induced Wheal
title_full Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine Induced Wheal
title_fullStr Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine Induced Wheal
title_full_unstemmed Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine Induced Wheal
title_sort Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine Induced Wheal
dc.creator.fl_str_mv Sánchez Caraballo, Jorge Mario
Zakzuk Sierra, Josefina
Cardona Villa, Ricardo
dc.contributor.author.none.fl_str_mv Sánchez Caraballo, Jorge Mario
Zakzuk Sierra, Josefina
Cardona Villa, Ricardo
dc.contributor.researchgroup.spa.fl_str_mv Grupo de Alergología Clínica y Experimental (GACE)
dc.subject.decs.none.fl_str_mv Enfermedad Crónica
Chronic Disease
Antagonistas de los Receptores Histamínicos
Histamine Antagonists
Urticaria
Estudios Prospectivos
Prospective Studies
topic Enfermedad Crónica
Chronic Disease
Antagonistas de los Receptores Histamínicos
Histamine Antagonists
Urticaria
Estudios Prospectivos
Prospective Studies
https://id.nlm.nih.gov/mesh/D002908
https://id.nlm.nih.gov/mesh/D006633
https://id.nlm.nih.gov/mesh/D014581
https://id.nlm.nih.gov/mesh/D011446
dc.subject.meshuri.none.fl_str_mv https://id.nlm.nih.gov/mesh/D002908
https://id.nlm.nih.gov/mesh/D006633
https://id.nlm.nih.gov/mesh/D014581
https://id.nlm.nih.gov/mesh/D011446
description ABSTRACT: Background: Antihistamines are the first line of treatment for chronic spontaneous urticaria. However, there is no effective method to predict whether an antihistamine will have a beneficial clinical effect or not. Objective: To assess whether the change in histamine-induced wheal and flare measurements 24 hours after administration of antihistamine can predict the efficacy of treatment. Methods: We performed a multicenter, triple-blind, randomized study. Patients received a daily oral dose of cetirizine, fexofenadine, bilastine, desloratadine, or ebastine over 8 weeks. After 4 weeks, a higher dose of antihistamine was administered to patients who did not experience a clinical response. A histamine skin prick test was carried out at baseline and 24 hours after the first dose of antihistamine. Disease severity (Urticaria Activity Score [UAS]), response to the histamine skin prick test, and impact on the patient's quality of life (Dermatology Life Quality Index [DLQI]) were determined every 2 weeks. Results: The study population comprised 150 patients (30 per group) and 30 controls. Twenty-four hours after administration of antihistamine, inhibition of the histamine wheal by >75% was significantly associated with better UAS and DLQI scores. The safety and efficacy of the 5 antihistamines were similar. After updosing, rates of disease control (DLQI score <5) increased from 58.7% to 76.7%. Conclusions: Measurement of the histamine-induced wheal can predict which patients will have a strong clinical response to antihistamines but has limited utility for identifying nonresponders. The clinical significance of these data could be relevant in the search for new urticaria treatment regimens.
publishDate 2016
dc.date.issued.none.fl_str_mv 2016
dc.date.accessioned.none.fl_str_mv 2024-11-04T23:58:40Z
dc.date.available.none.fl_str_mv 2024-11-04T23:58:40Z
dc.type.spa.fl_str_mv Artículo de investigación
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Sánchez J, Zakzuk J, Cardona R. Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine- Induced Wheal. J Investig Allergol Clin Immunol. 2016;26(3):177-84. doi: 10.18176/jiaci.0039.
dc.identifier.issn.none.fl_str_mv 1018-9068
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/43153
dc.identifier.doi.none.fl_str_mv 10.18176/jiaci.0039
identifier_str_mv Sánchez J, Zakzuk J, Cardona R. Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine- Induced Wheal. J Investig Allergol Clin Immunol. 2016;26(3):177-84. doi: 10.18176/jiaci.0039.
1018-9068
10.18176/jiaci.0039
url https://hdl.handle.net/10495/43153
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv J. Investig. Allergol. Clin. Immunol.
dc.relation.citationendpage.spa.fl_str_mv 184
dc.relation.citationissue.spa.fl_str_mv 3
dc.relation.citationstartpage.spa.fl_str_mv 177
dc.relation.citationvolume.spa.fl_str_mv 26
dc.relation.ispartofjournal.spa.fl_str_mv Journal of Investigational Allergology and Clinical Immunology
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
https://creativecommons.org/licenses/by-nc-nd/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 8 páginas
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Esmon Publicidad
dc.publisher.place.spa.fl_str_mv Barcelona, España
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstreams/00fc8e02-55d6-460c-9494-b19eae0171ea/download
https://bibliotecadigital.udea.edu.co/bitstreams/ac11d027-b096-4d40-884a-c6341591589a/download
https://bibliotecadigital.udea.edu.co/bitstreams/4a2df7a7-5927-4a05-b317-9b542365d613/download
https://bibliotecadigital.udea.edu.co/bitstreams/d451ef25-78fe-4e41-866d-120fe5bbea04/download
https://bibliotecadigital.udea.edu.co/bitstreams/89f095db-45fb-48ce-99e5-479b17cb00ef/download
bitstream.checksum.fl_str_mv a22ea08a8e7f3bc2ed683216e8772084
b88b088d9957e670ce3b3fbe2eedbc13
8a4605be74aa9ea9d79846c1fba20a33
05acc158581a57edf7b390fe55c0f1aa
92baaa7da07763d7ca13c896cf019cea
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de la Universidad de Antioquia
repository.mail.fl_str_mv aplicacionbibliotecadigitalbiblioteca@udea.edu.co
_version_ 1851052526815674368
spelling Sánchez Caraballo, Jorge MarioZakzuk Sierra, JosefinaCardona Villa, RicardoGrupo de Alergología Clínica y Experimental (GACE)2024-11-04T23:58:40Z2024-11-04T23:58:40Z2016Sánchez J, Zakzuk J, Cardona R. Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine- Induced Wheal. J Investig Allergol Clin Immunol. 2016;26(3):177-84. doi: 10.18176/jiaci.0039.1018-9068https://hdl.handle.net/10495/4315310.18176/jiaci.0039ABSTRACT: Background: Antihistamines are the first line of treatment for chronic spontaneous urticaria. However, there is no effective method to predict whether an antihistamine will have a beneficial clinical effect or not. Objective: To assess whether the change in histamine-induced wheal and flare measurements 24 hours after administration of antihistamine can predict the efficacy of treatment. Methods: We performed a multicenter, triple-blind, randomized study. Patients received a daily oral dose of cetirizine, fexofenadine, bilastine, desloratadine, or ebastine over 8 weeks. After 4 weeks, a higher dose of antihistamine was administered to patients who did not experience a clinical response. A histamine skin prick test was carried out at baseline and 24 hours after the first dose of antihistamine. Disease severity (Urticaria Activity Score [UAS]), response to the histamine skin prick test, and impact on the patient's quality of life (Dermatology Life Quality Index [DLQI]) were determined every 2 weeks. Results: The study population comprised 150 patients (30 per group) and 30 controls. Twenty-four hours after administration of antihistamine, inhibition of the histamine wheal by >75% was significantly associated with better UAS and DLQI scores. The safety and efficacy of the 5 antihistamines were similar. After updosing, rates of disease control (DLQI score <5) increased from 58.7% to 76.7%. Conclusions: Measurement of the histamine-induced wheal can predict which patients will have a strong clinical response to antihistamines but has limited utility for identifying nonresponders. The clinical significance of these data could be relevant in the search for new urticaria treatment regimens.RESUMEN: Antecedentes: Los antihistamínicos son la primera línea de tratamiento en la urticaria crónica espontanea (UCS) pero actualmente no hay un método eficaz para predecir si un antihistamínico tendrá un efecto clínico beneficioso o no. Objetivo: Evaluar si la prueba cutánea con histamina puede predecir la efectividad del tratamiento con antihistamínicos. Métodos: Se realizó un estudio multicéntrico, triple ciego, aleatorizado. Los pacientes recibieron una dosis oral diaria de cetirizina, fexofenadina, bilastina, desloratadina o ebastina durante 8 semanas. Después de 4 semanas, en los pacientes sin respuesta clínica, se administró una dosis más alta de antihistamínico. Al inicio del estudio, después de 24 horas y cada dos semanas tras la primera administración de los antihistamínicos, se llevó a cabo una prueba intraepidérmica con histamina. La severidad de la enfermedad (escala UAS) y el impacto en la calidad de vida de los pacientes (escala DLQI) fueron evaluados cada dos semanas. Resultados: 150 pacientes (n = 30, en cada grupo) y 30 sujetos control participaron en este estudio. Después de 24 horas de la administración de antihistamínicos, una inhibición de histamina mayor al 75% del basal, se asoció significativamente con mejores resultados en el UAS y el DLQI. La seguridad y eficacia de los cinco antihistamínicos fueron similares. Después de aumentar la dosis, las tasas de control de la enfermedad (puntuación DLQI <5) paso de 58,7% a 76,7%. Conclusiones: La prueba intraepidérmica con histamina es útil para predecir a los pacientes que tendrán una importante respuesta clínica a los antihistamínicos, pero tiene una utilidad limitada para la identificación de los no respondedores. Estos datos pueden ser relevantes en el momento de establecer nuevos esquemas para el tratamiento de la urticaria.COL00595678 páginasapplication/pdfengEsmon PublicidadBarcelona, Españahttp://creativecommons.org/licenses/by-nc-nd/2.5/co/https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine Induced WhealArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionEnfermedad CrónicaChronic DiseaseAntagonistas de los Receptores HistamínicosHistamine AntagonistsUrticariaEstudios ProspectivosProspective Studieshttps://id.nlm.nih.gov/mesh/D002908https://id.nlm.nih.gov/mesh/D006633https://id.nlm.nih.gov/mesh/D014581https://id.nlm.nih.gov/mesh/D011446J. Investig. Allergol. Clin. Immunol.184317726Journal of Investigational Allergology and Clinical ImmunologyPublicationORIGINALCardonaRicardo_2016_Prediction_Efficacy_Antihistamines.pdfCardonaRicardo_2016_Prediction_Efficacy_Antihistamines.pdfArtículo de investigaciónapplication/pdf471782https://bibliotecadigital.udea.edu.co/bitstreams/00fc8e02-55d6-460c-9494-b19eae0171ea/downloada22ea08a8e7f3bc2ed683216e8772084MD51trueAnonymousREADCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823https://bibliotecadigital.udea.edu.co/bitstreams/ac11d027-b096-4d40-884a-c6341591589a/downloadb88b088d9957e670ce3b3fbe2eedbc13MD52falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/4a2df7a7-5927-4a05-b317-9b542365d613/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADTEXTCardonaRicardo_2016_Prediction_Efficacy_Antihistamines.pdf.txtCardonaRicardo_2016_Prediction_Efficacy_Antihistamines.pdf.txtExtracted texttext/plain37172https://bibliotecadigital.udea.edu.co/bitstreams/d451ef25-78fe-4e41-866d-120fe5bbea04/download05acc158581a57edf7b390fe55c0f1aaMD54falseAnonymousREADTHUMBNAILCardonaRicardo_2016_Prediction_Efficacy_Antihistamines.pdf.jpgCardonaRicardo_2016_Prediction_Efficacy_Antihistamines.pdf.jpgGenerated Thumbnailimage/jpeg15057https://bibliotecadigital.udea.edu.co/bitstreams/89f095db-45fb-48ce-99e5-479b17cb00ef/download92baaa7da07763d7ca13c896cf019ceaMD55falseAnonymousREAD10495/43153oai:bibliotecadigital.udea.edu.co:10495/431532025-03-26 23:48:06.437http://creativecommons.org/licenses/by-nc-nd/2.5/co/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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